SEC Form 4 · accession 0001209191-16-118290
Zosano Pharma Corp · ZSAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Peter Walker
Director
Period of report
May 4, 2016
Accepted (ET)
May 6, 2016 · 9:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.11 | May 4, 2016 | A | 6,813 | A | — | May 4, 2026 | Common Stock | 6,813 | 6,813 | D |
| Restricted Stock UnitsF2,F3 | — | May 4, 2016 | A | 9,478 | A | — | — | Common Stock | 9,478 | 9,478 | D |
Explanation of responses
- F1The shares underlying the option vest over one year in 12 monthly installments, beginning on June 4, 2016.
- F2Each restricted stock unit represents a contingent right to receive one share of ZSAN common stock; vested restricted stock units are payable in the form of cash, shares of ZSAN common stock, or a combination thereof.
- F3The restricted stock units vest 100% on the one year anniversary of the date of grant. To the extent vested restricted stock units are paid in shares of the Issuer's common stock, such shares will be delivered to the reporting person as soon as possible after vesting.